IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MORGANTI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 915
EU - Europa 829
AS - Asia 664
AF - Africa 55
SA - Sud America 47
OC - Oceania 37
Totale 2.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 832
IT - Italia 333
CN - Cina 250
GB - Regno Unito 122
IN - India 106
JP - Giappone 76
CA - Canada 58
DE - Germania 56
FR - Francia 53
HK - Hong Kong 37
IE - Irlanda 37
AU - Australia 33
ES - Italia 33
NL - Olanda 33
TR - Turchia 23
IL - Israele 21
ID - Indonesia 19
MX - Messico 19
GR - Grecia 18
PL - Polonia 15
RO - Romania 15
RU - Federazione Russa 15
CL - Cile 13
KR - Corea 13
IR - Iran 12
MY - Malesia 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
PH - Filippine 11
SG - Singapore 11
CO - Colombia 10
CZ - Repubblica Ceca 10
SE - Svezia 10
VN - Vietnam 10
FI - Finlandia 9
MK - Macedonia 9
NG - Nigeria 9
PT - Portogallo 9
BA - Bosnia-Erzegovina 8
BR - Brasile 8
DK - Danimarca 8
EG - Egitto 8
IQ - Iraq 8
BE - Belgio 7
CH - Svizzera 7
PK - Pakistan 7
UA - Ucraina 7
AE - Emirati Arabi Uniti 5
AR - Argentina 5
KE - Kenya 5
MA - Marocco 5
MO - Macao, regione amministrativa speciale della Cina 5
TH - Thailandia 5
TW - Taiwan 5
VE - Venezuela 5
CU - Cuba 4
CY - Cipro 4
DZ - Algeria 4
GH - Ghana 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
AT - Austria 3
CM - Camerun 3
EC - Ecuador 3
HR - Croazia 3
JO - Giordania 3
LB - Libano 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
LY - Libia 2
PE - Perù 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
KG - Kirghizistan 1
LV - Lettonia 1
MW - Malawi 1
NO - Norvegia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
YE - Yemen 1
Totale 2.547
Salva come PNG Salva come JPEG
Città #
Milan 97
Beijing 65
Ashburn 59
Fairfield 37
Shanghai 37
Dublin 36
Rome 34
Santa Cruz 32
Ottawa 28
Seattle 23
Houston 22
Ann Arbor 19
New York 19
Cambridge 17
Chicago 17
Tokyo 16
Bussum 15
Naples 15
Chennai 14
Dallas 14
Boardman 13
Buffalo 13
Central 13
Istanbul 13
Santiago 13
Southend 13
Delhi 12
Provo 12
Athens 11
Brisbane 11
Guangzhou 11
Los Angeles 11
Barcelona 10
Frankfurt am Main 10
Lucknow 10
Mumbai 10
Madrid 9
San Diego 9
San Francisco 9
Woodbridge 9
Berlin 8
Bogotá 8
Columbus 8
Helsinki 8
Jeddah 8
Kunming 8
London 8
San Jose 8
Singapore 8
Beersheba 7
Gdansk 7
Hangzhou 7
Hefei 7
Manchester 7
Nagoya 7
Osaka 7
Stockholm 7
Turin 7
Amsterdam 6
Atlanta 6
Bologna 6
Boston 6
Sarajevo 6
Adelaide 5
Bucharest 5
Dudenhofen 5
Duncan 5
Genoa 5
Hyderabad 5
Lisbon 5
Mcallen 5
Mexico City 5
Ocala 5
Pune 5
Rho 5
São Paulo 5
Angeles City 4
Auckland 4
Bengaluru 4
Birmingham 4
Brooklyn 4
Brussels 4
Caracas 4
Chapel Hill 4
Durham 4
Fremont 4
Havana 4
Hong Kong 4
Jaipur 4
Kota Bharu 4
Mainz 4
Nicosia 4
Nuremberg 4
Oakville 4
Ostrava 4
Padova 4
Paris 4
Piscataway 4
Santa Clara 4
Saskatoon 4
Totale 1.164
Salva come PNG Salva come JPEG
Nome #
Biologic therapy for advanced breast cancer : recent advances and future directions, file dfa8b9a5-fa2f-748b-e053-3a05fe0a3a96 1.129
Margetuximab for the treatment of HER2-positive metastatic breast cancer, file dfa8b9a6-578b-748b-e053-3a05fe0a3a96 830
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials, file dfa8b9a5-dfe5-748b-e053-3a05fe0a3a96 117
Antibody–drug conjugates in solid tumors: a look into novel targets, file dfa8b9a6-4a77-748b-e053-3a05fe0a3a96 101
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management, file dfa8b9a7-b359-748b-e053-3a05fe0a3a96 80
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study, file dfa8b9a3-9131-748b-e053-3a05fe0a3a96 79
Master protocols in immuno-oncology : Do novel drugs deserve novel designs?, file dfa8b9a5-ca70-748b-e053-3a05fe0a3a96 74
Combinations using checkpoint blockade to overcome resistance, file dfa8b9a6-4929-748b-e053-3a05fe0a3a96 53
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials, file dfa8b9aa-2ac0-748b-e053-3a05fe0a3a96 51
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials, file dfa8b9a9-e0ee-748b-e053-3a05fe0a3a96 29
Systemic Treatment of Ductal Carcinoma In Situ of the Breast, file dfa8b9a9-9c49-748b-e053-3a05fe0a3a96 18
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients, file dfa8b9a2-c08f-748b-e053-3a05fe0a3a96 5
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials, file dfa8b9a8-17a4-748b-e053-3a05fe0a3a96 5
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer, file cc94710a-5f6c-41a2-a391-41255a410895 3
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life, file dfa8b99d-3bcc-748b-e053-3a05fe0a3a96 3
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents, file 7274a766-ca39-47ea-b580-0b41c0acc128 2
HER2-Low Breast Cancer: Pathological and Clinical Landscape, file dfa8b9a2-e9d0-748b-e053-3a05fe0a3a96 2
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy : A critical review of published data, file dfa8b9a5-dd32-748b-e053-3a05fe0a3a96 2
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis, file dfa8b9a6-2d2d-748b-e053-3a05fe0a3a96 2
COVID-19 related risk in patients enrolled in early-phase clinical trials, file 70b0e2e5-056a-4944-94f5-f40366a71c4f 1
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari., file 7f3077be-5ed4-4015-b402-883b72eb87a8 1
Characterization of low HER2 expressions in de-novo metastatic breast cancer, file bf38567a-0f9f-4a8e-8e20-0fa2d2e229ca 1
What therapies are on the horizon for HER2 positive breast cancer?, file dfa8b99f-2ed0-748b-e053-3a05fe0a3a96 1
Optimizing treatment strategy in early breast cancer: less is more, or more is better?, file dfa8b99f-5bfc-748b-e053-3a05fe0a3a96 1
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients, file dfa8b9a3-85d3-748b-e053-3a05fe0a3a96 1
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2, file dfa8b9a6-1fad-748b-e053-3a05fe0a3a96 1
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions, file dfa8b9a9-84e4-748b-e053-3a05fe0a3a96 1
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?, file dfa8b9a9-c137-748b-e053-3a05fe0a3a96 1
Clinical development and current role of margetuximab for the treatment of breast cancer, file dfa8b9a9-c449-748b-e053-3a05fe0a3a96 1
Totale 2.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 3 0
2019/20202 0 0 2 0 0 0 0 0 0 0 0 0
2020/202194 4 2 0 2 4 1 8 1 20 11 30 11
2021/2022876 30 11 12 40 64 91 84 90 118 99 146 91
2022/2023960 62 63 127 103 92 71 77 93 62 81 75 54
2023/2024660 39 44 69 58 58 99 76 98 60 59 0 0
Totale 2.595